3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
28
Leukemia, Lymphocytic, Chronic, B-Cell
14
Myelodysplastic Syndromes
6
Waldenstrom Macroglobulinemia
5
Lymphoma, B-Cell, Marginal Zone
5
Burkitt Lymphoma
5
Lymphoma, Mantle-Cell
4
Lymphoma, Non-Hodgkin
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma
3
Recurrence
2
Neoplasms
2
Myeloproliferative Disorders
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Biphenotypic, Acute
2
Leukemia
2
Hematologic Neoplasms
2
Blast Crisis
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Multiple Myeloma
1
Lymphoma, Follicular
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myeloid
1
GATA2 Deficiency
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
obinutuzumab
1
glofitamab
1
fludarabine phosphate
1
Whole-Body Irradiation
1
Tacrolimus
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Etoposide
1
Cyclosporine
1
Cyclophosphamide
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Dendritic Cell Sarcoma, Interdigitating
×
venetoclax
×
30 days
×
Clear all
No trials found.